M&S Biotics, Inc. is a healthcare Internet of Things (IoT) company focused on improving a surgical procedure’s efficiency, efficacy, and safety by implementing our Biotic Integration system. This company was born out of the necessity to put patient care first while alleviating the strain healthcare institutions face with rising costs, limited resources, and an uncertain regulatory landscape.
Our CEO and Founder Joshua Mecca underwent a kidney transplant on August 8th, 2013. Although the surgery was successful, Josh’s due diligence about the procedure discovered significant inefficiencies, safety concerns, and unnecessary risks that each and every patient faces when they undergo a surgical procedure. This inspired Josh to take action and develop a solution to ensure every operating room equipped with M&S Biotics’ “Smart Table” will perform more efficient, effective, and safer surgical procedures.
CEO and Founder
M.Sci in Bioengineering (Biotechnology) with six years of experience concerning molecular compounds. However, he pivoted his career to computer science and sensor technology, with a focus on system integration, data computation, data analytics, system architecture, UI/UX design, and data migration. This work resulted in two patents and proprietary CART algorithms pertaining to the core technology at M&S Biotics.
Director of Clinical Operations
Drew earned his an M.Eng (Bioengineering) at Rice University with a special concentration in late-stage medical device development. Drew manages all aspects of M&S Biotics’ clinical operations as it pertains to grant solicitations, research, pilots, and establishing partnerships between M&S Biotics and healthcare facilities.
Dr. Steven A. Curley specializes in providing surgical care for patients with hepatobiliary and pancreatic malignancies. Currently, Dr. Curley is the Oncology Institute Director, Chief of Surgical Oncology at Christus Health Systems. An award-winning physician, distinguished colleague, and published Author. Dr. Curley provides insights from an extensive academic career and clincal practice.
Toby Hamilton, M.D., F.A.C.E.P., a founding partner, chairman of the board of directors and chief executive officer of Emerus Hospitals, is among “110 Physician Leaders of Hospitals and Health Systems for 2016,” according to Becker’s Hospital Review.
Dr. Hamiltion currently serves as the Associate Director of Biodesign at TMCx (The Texas Medical Center’s Premier Accelerator where he guides teams leading development in the next generation of medical devices and digital health solutions.
Dr. David H. Berger now serves as Senior Vice President and Chief Operating Officer of Central Florida Florida Health. He was previously a Houston resident serving as the Senior Vice President and Chief Operating Officer at Baylor St. Luke’s Medicine Medical Center. Another role that he served in was the operative care line executive at the Michael E. DeBakey VA Medical Center. He was recently elected president of the Association of VA Surgeons and is past-president of the Association for Academic Surgery. He is well known for his success in implementing process and quality improvements at the DeBakey VA Medical Center.
Chris Wehr, M.D. spent 20 years as a Cardiothoracic surgeon treating critically ill patients. A major centerpiece to Dr. Wehr’s career was his involvement in the initiation of the surgical “time out”, along with other safety initiatives. These proactive approaches lead to his current focus on Regenerative Medicine and anti-aging where he practices at Bodylogic MD in Orlando, Florida.
Dr. Lambert specializes in colorectal surgeries and completed his training at the University of Florida College of Medicine. While earning completing his residency, Dr. Lambert also earned is Masters of Business Administration (MBA) at the University of Florida’s Hough Graduate School of Business.
